ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 114 filers reported holding ACCELERON PHARMA INC in Q4 2014. The put-call ratio across all filers is 0.52 and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $3,614,000 | +9938.9% | 21,002 | +7400.7% | 0.00% | – |
Q4 2020 | $36,000 | -89.4% | 280 | -96.1% | 0.00% | -100.0% |
Q1 2019 | $339,000 | +3.0% | 7,269 | -3.7% | 0.00% | +33.3% |
Q4 2018 | $329,000 | +181.2% | 7,548 | +140.8% | 0.00% | +200.0% |
Q3 2017 | $117,000 | +680.0% | 3,134 | +458.6% | 0.00% | – |
Q1 2016 | $15,000 | +400.0% | 561 | +819.7% | 0.00% | – |
Q4 2015 | $3,000 | -98.8% | 61 | -99.1% | 0.00% | -100.0% |
Q1 2015 | $247,000 | +4016.7% | 6,479 | +3139.5% | 0.00% | – |
Q3 2014 | $6,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |